Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein. 1995

A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
Department of Biochemistry, Hokkaido University School of Medicine, Sapporo, Japan.

Experimental arthritis was induced in the knee joint of transgenic mice expressing human alpha-fetoprotein by immunization with methylated bovine serum albumin in Freund's complete adjuvant. In the control experiment with normal C57BL/6 mice, definite arthritis was observed in 55.6% (5/9) of the mice, but in only 21.1% (4/19) of the transgenic mice. This result suggested that human alpha-fetoprotein functioned as an immunosuppressant to ameliorate the development of the immune disease.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
January 1999, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
October 1980, Gan,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
March 1993, Biochemical and biophysical research communications,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
April 1984, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
December 2002, Arthritis and rheumatism,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
December 1983, Gan,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
January 1997, Oncology reports,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
January 1985, Cold Spring Harbor symposia on quantitative biology,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
July 1985, Molecular and cellular biology,
A Ogata, and T Yamashita, and Y Koyama, and M Sakai, and S Nishi
October 2020, Scientific reports,
Copied contents to your clipboard!